Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)-Reference-Cited by-同舟云学术

Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Published:2017-08-30 Issue:11 Volume:96 Page:1775-1792
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Heinz W. J.,Buchheidt D.,Christopeit M.,von Lilienfeld-Toal M.,Cornely O. A.,Einsele H.,Karthaus M.,Link H.,Mahlberg R.,Neumann S.,Ostermann H.,Penack O.,Ruhnke M.,Sandherr M.,Schiel X.,Vehreschild J. J.,Weissinger F.,Maschmeyer G.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-017-3098-3/fulltext.html

Reference147 articles.

1. Bodey GP (1966) Infectious complications of acute leukemia. Med Times 94(9):1076–1085

2. Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106(10):2258–2266. doi: 10.1002/cncr.21847

3. Link H, Böhme A, Cornely OA, Höffken K, Kellner O, Kern WV, Mahlberg R, Maschmeyer G, Nowrousian MR, Ostermann H, Ruhnke M, Sezer O, Schiel X, Wilhelm M, Auner HW (2003) Antimicrobial therapy of unexplained fever in neutropenic patients—guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol 82(Suppl 2):S105–S117. doi: 10.1007/s00277-003-0764-4

4. Penack O, Becker C, Buchheidt D, Christopeit M, Kiehl M, von Lilienfeld-Toal M, Hentrich M, Reinwald M, Salwender H, Schalk E, Schmidt-Hieber M, Weber T, Ostermann H (2014) Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of hematology and medical oncology (AGIHO). Ann Hematol 93(7):1083–1095. doi: 10.1007/s00277-014-2086-0

5. Neumann S, Krause SW, Maschmeyer G, Schiel X, von Lilienfeld-Toal M (2013) Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 92(4):433–442. doi: 10.1007/s00277-013-1698-0

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interventional antibiotic treatment replacing antibiotic prophylaxis during allogeneic hematopoietic stem cell transplantation is safe and leads to a reduction of antibiotic administration;Annals of Hematology;2024-09-06

2. Variation in Antibiotic Prescription in High-Risk Febrile Neutropenia in Portuguese Hospitals;Antibiotics;2024-08-30

3. Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities;Intensive Care Medicine;2024-08-22

4. How can we optimize antifungal use and stewardship in the treatment of acute leukemia?;Expert Review of Hematology;2024-07-25

5. Seven-day antibiotic therapy for Enterobacterales bacteremia in high-risk neutropenic patients: toward a new paradigm;European Journal of Clinical Microbiology & Infectious Diseases;2024-07-03